Our Mission: Cure Desmoid Tumors
The Desmoid Tumor Research Foundation (DTRF) empowers and unites everyone committed to finding answers for the desmoid tumor community. We aggressively fund desmoid tumor research, accelerate the development of improved therapies, drive collaborations among clinicians and researchers worldwide, and support patients and doctors through education. Our goal is to find a cure for each and every patient diagnosed with this rare disease.
Learn more about submitting a grant proposal.
EXPLORE THE RESEARCH WE’VE FUNDED AT PRESTIGIOUS INSTITUTIONS AROUND THE WORLD.
| Year | Principal Investigator | Award Title | |
|---|---|---|---|
| Year2010 | Principal InvestigatorAndrew Beck, MD, Post Doc Fellow, Stanford University | Award Title“Evaluation of large intergenic non-coding RNAs in desmoid type fibromatosis.” Year 1 of 1 | View Project |
| Year2009 | Principal InvestigatorBenjamin A. Alman, MD, University of Toronto | Award Title“Identifying the desmoid initiating cell.” Year 3 of 3 | View Project |
| Year2009 | Principal InvestigatorDina Lev, MD et al, MD Anderson Cancer Center, University of Texas | Award Title“Molecular determinants of desmoid tumor development and progression.” Year 3 of 3 | View Project |
| Year2009 | Principal InvestigatorRichard D. Lackman, MD, University of Pennsylvania | Award Title“The role of hydroxyurea as first line treatment for primary and recurrent/refractory desmoid tumors.” Year 1 of 1 | View Project |
| Year2009 | Principal InvestigatorMatt van de Rijn, MD, PhD, Stanford University | Award Title“ROR2, a potential novel therapeutic target in desmoid tumors.” Year 2 of 2 | View Project |
| Year2008 | Principal InvestigatorBenjamin A. Alman, MD et al, The Hospital for Sick Children, Toronto | Award Title“Identifying the desmoid initiating cell.” Year 2 of 3 | View Project |
| Year2008 | Principal InvestigatorDina Lev, MD et al, MD Anderson Cancer Center, University of Texas | Award Title“Molecular determinants of desmoid tumor development and progression.” Year 2 of 3 | View Project |
| Year2008 | Principal InvestigatorDavid E. Joyner, PhD, Huntsman Institute, University of Utah | Award Title“Do factors mediate desmoid tumor invasiveness and drug sensitivity?” Year 2 of 2 | View Project |
| Year2008 | Principal InvestigatorMatt van de Rijn, MD, PhD, Stanford University | Award Title“ROR2, a potential novel therapeutic target in desmoid tumors.” Year 1 of 2 | View Project |
| Year2007 | Principal InvestigatorDavid E. Joyner, PhD et al, Huntsman Institute, University of Utah | Award Title“Do factors mediate desmoid tumor invasiveness and drug Sensitivity?” Year 1 of 2 | View Project |
Clinicians & Researchers Newsletter
Receive monthly updates about treatment advances, grant applications, clinical trials, CME opportunities, and more.
